OUR EXPERTISES
Cure51 gathers talents coming from various areas of expertise – from biocomputation, to data engineering, biological samples analysis or Tech infrastructure – all driven by the same passion : cure cancer.
At Cure51 our mission is to create the first worldwide database of cancer survivors to leverage their exceptional biological features and find new drugs to cure Cancer.
Cure51 gathers talents coming from various areas of expertise – from biocomputation, to data engineering, biological samples analysis or Tech infrastructure – all driven by the same passion : cure cancer.
We have identified patients in more than 50 countries, reflecting human diversity and fostering collaboration with outstanding researchers and clinicians all around the world.
Nicolas Wolikow
Co-Founder & Chief Executive Officer
Simon Istolainen
Co-Founder, Chief Strategy & Scientific Network
El Mehdi Ouzgane
Chief Operating Officer
Emna Makhlouf
Chief of Staff
Eric Delaloy
Head of Design
Rémy Nicolle
Co-founder, Senior Scientific Advisor Computational Biology
Anne Thomsen
Head of Legal
Anne Lecadieu
Head of Sales & Partnerships
Marine Otero Del Val
Head of Product
Paloma Cejas, PhD
Chief of Biology
Louis-Baptiste France
Head of Engineering
David Ouaknine
Chief Financial Officer
Nick Riddiford
Head of Computational Biology
Elisabeth Auzias
Scientific Project Manager
Omar Choufani
Operations Project Manager
Rashad Merhi
Financial Controler
Mohamed Azerkane
Tech lead
Naouel Zerrouk
Bio-Info
Maria Gerogianni
Clinical Network Project Manager
Perla Zana
Full Stack Dev
Pierre Martin
Full Stack Dev
Damien Léger
DevSecOps
Kevin Weiss
Data Engineer
Clarisse Charuel
Full Stack Dev
Want to get in touch? Reach out to our team or follow us on our social networks.
Cure51 is HDS labelised
and ISO 27001 certified
